Sebastian Soidinsalo

Profile

I work at the interface of science, strategy, and execution, with a focus on turning high-potential research into credible biotech companies. My background spans venture creation, early-stage company building, scientific positioning, commercial framing, and investor-facing communication in life sciences.

Capabilities

Areas where I work

• Venture creation

  Building around differentiated science requires focus, prioritization, and a credible path from discovery to company.

• Science-to-strategy translation

  Working across complex therapeutic concepts and translating them into strategic direction, positioning, and external narratives.

• Opportunity assessment

  Evaluating where value may lie, what the key risks are, and what deserves to be built.

• Investor and partner readiness

  Helping shape opportunities into forms that are clear, disciplined, and credible to external stakeholders.

• Execution in ambiguity

  Operating in early-stage environments where data are incomplete and the right next step is not always obvious.

Bio

Sebastian is a Finnish biotech operator and co-founder and COO of Polku Therapeutics. His work spans scientific strategy, commercial framing, financing, and external engagement — the functions that move early translational science toward a credible company.

His long-term interest is in company creation around strong translational science, with particular attention to brain health and therapeutics.

Contact

Get in touch

I’m always open to thoughtful conversations around biotech company creation, therapeutic innovation, and early-stage strategy.

Also on LinkedIn.